MedPath

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Not Applicable
Recruiting
Conditions
Cutaneous Melanoma, Stage II
Interventions
Procedure: Wide Local Excision = 2cm Margin
Procedure: Wide Local Excision = 1cm Margin
Registration Number
NCT03860883
Lead Sponsor
Melanoma and Skin Cancer Trials Limited
Brief Summary

Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.

Detailed Description

This study will determine whether there is a difference in disease-free survival rates for patients with primary cutaneous melanoma with Breslow thickness \> 2mm or 1-2mm with ulceration (pT2b-pT4b, AJCC 8th edition), treated with either a 1cm excision margin or 2cm margin. The study is designed to be able to prove or disprove that there is no difference in risk of the tumour recurring around the scar or anywhere else in the body between the two groups of patients. If the study shows no risk of tumour recurrence then we will also be able to determine how much of an impact the narrower excision has on patients in terms of improved quality of life and reduced side effects from the surgery and melanoma disease. This trial will also evaluate and determine the economic impact of narrower excision margins on the health services and society in general.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2998
Inclusion Criteria

Patients may be included in the study if they meet ALL of the following criteria:

    1. Patients must have a Stage II primary invasive cutaneous melanoma (pT2b-pT4b, AJCC 8th edition) with Breslow thickness >1.0mm to 2.0mm; >2.0mm to 4.0mm or >4.0mm with ulceration, or >2.0mm to 4.0mm; or >4.0mm without ulceration (Table 1) as determined by diagnostic biopsy (narrow excision, incision, shave or punch biopsy) and subsequent histopathological analysis.
  1. Must have a primary melanoma that is cutaneous (including head, neck, trunk, extremity, scalp, palm or sole).

  2. An uninterrupted 2cm margin must be technically feasible around biopsy scar or primary melanoma.

    1. Surgical intervention (which refers to the staging -SLNB and WLE as these are both to be done on the same day) must be completed within 120 days of the original diagnosis. Surgical intervention must also be performed within 28 days of randomisation.
  3. Patients must be 18 years or older at time of consent.

  4. Patient must be able to give informed consent and comply with the treatment protocol and follow up plan.

  5. Life expectancy of at least 5 years from the time of diagnosis, not considering the melanoma in question, as determined by the PI.

  6. Patients must have an ECOG performance score between 0 and 1 at screening.

  7. A survivor of prior cancer is eligible provided that ALL of the following criteria are met and documented:

    • The patient has undergone potentially curative therapy for all prior malignancies,
    • There has been no evidence of recurrence of any prior malignancies for at least FIVE years (with the exception of successfully treated uterine/cervical or non-melanoma skin cancers (SCCs/BCCs) with no evidence of recurrence), and
    • The patient is deemed by their treating physician to be at low risk of recurrence from previous malignancies.
Exclusion Criteria

Patients will be excluded from the study for ANY of the following reasons:

  1. Uncertain diagnosis of melanoma i.e., so-called 'melanocytic lesion of unknown malignant potential'.
  2. Patient has already undergone WLE at the site of the primary index lesion.
  3. Patient unable or ineligible to undergo staging SLNB of the primary index lesion.
  4. Perineural invasion or neurotropic melanoma: Neurotropism or perineural invasion in any type of melanoma is an exclusion. Perineural invasion does not include entrapment of nerves within the main primary tumour mass.
  5. Desmoplastic melanoma: with any patient where pathology determines melanoma as PURE desmoplastic (as per WHO definition of >90% desmoplasia), they are not eligible for this study. However melanomas with less than 90% desmoplasia or mixed desmoplastic subtypes are eligible unless there is neurotropism present (perineural invasion).
  6. Microsatellitosis (a nest of metastatic tumour cells found to be growing away from the primary tumour) as per AJCC 8th edition definition is an exclusion.
  7. Subungual melanoma
  8. Patient has already undergone a local flap reconstruction of the defect after excision of the primary and determination of an accurate excision margin is impossible.
  9. History of previous or concurrent (i.e. >1 primary melanoma) invasive melanoma.
  10. Melanoma located distal to the metacarpophalangeal joint; on the tip of the nose; the eyelids or on the ear; genitalia, perineum or anus; mucous membranes or internal viscera.
  11. Physical, clinical, radiographic or pathologic evidence of satellite, in-transit, regional, or distant metastatic melanoma.
  12. Patient has undergone surgery on a separate occasion to clear the lymph nodes of the probable draining lymphatic field, including -SLNB, of the index melanoma.
  13. Any additional solid tumour or hematologic malignancy during the past 5 years (with exception of non- melanoma skin cancers (T1 skin lesions of squamous cell carcinoma (SCCs), basal cell carcinoma (BCCs)), or uterine/cervical cancer).
  14. Melanoma-related operative procedures not corresponding to criteria described in the protocol.
  15. Planned adjuvant radiotherapy to the primary melanoma site after wide local excision is not permitted as part of the protocol and any patients given this treatment would be excluded from the study.
  16. History of organ transplantation.
  17. Oral or parenteral immunosuppressive agents (not topical or inhaled steroids) at enrolment or within 6 months prior to enrolment.

Pregnancy is not a specific exclusion criterion for this trial, though it may not be clinically appropriate to perform a wide excision and SLNB until the pregnancy has been completed, which may exclude the patient due to violation of inclusion criterion 4. We would advise careful counselling of the patient prior to enrolling the patient, which would include a discussion at the treating centre's multidisciplinary team meeting or tumour board. We would strongly advise contacting the central trial office to discuss the case prior to enrolling on the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm B (Wide Local Excision = 2cm Margin)Wide Local Excision = 2cm Margin2 cm Wide Local Excision margin + Sentinel Lymph Node Biopsy +/- Reconstruction
Arm A (Wide Local Excision = 1cm Margin)Wide Local Excision = 1cm Margin1cm Wide Local Excision margin + Sentinel Lymph Node Biopsy +/- Reconstruction
Primary Outcome Measures
NameTimeMethod
Disease-Free Survival0-60 months

Time from randomisation until the first clinically, histologically or radiologically confirmed recurrence of melanoma at any body site, or death from any cause.

Secondary Outcome Measures
NameTimeMethod
Serious Adverse Eventsfrom randomisation up to 12-months post-surgery

All Serious Adverse events (SAEs), will be recorded from randomisation until 12 months post the surgical intervention or until the patient withdraws or dies.

Surgery Related Adverse EventsUp to 12-months from the date of surgery

The following surgical-related adverse events will be recorded from the time of surgery to 12-months following surgery (inclusive):

* wound dehiscence

* seroma/haematoma

* haemorrhage

* infection

* skin graft failure

* necrosis of flap used for reconstruction

* deep venous thrombosis

* urinary tract infection

* pneumonia

* cardiac complications

* lymphoedema

Local RecurrenceDay 0-Trial Completion (max. 120 months)

Time from randomisation to any clinically, histologically or radiologically confirmed LR of melanoma including satellite lesions and in transit metastases between the primary site and the regional draining lymph nodes or death from any cause.

Distant Disease-Free SurvivalDay 0-Trial Completion (max. 120 months)

Time from randomisation to any clinically, histologically or radiologically confirmed distant recurrence of melanoma or death from any cause

Melanoma-Specific SurvivalDay 0-Trial Completion (max. 120 months)

Time from randomisation to death due to melanoma

Overall SurvivalDay 0-Trial Completion (max. 120 months)

Time from randomisation to death from any cause

Melanoma-specific Quality of Life: FACT-M questionnaireBaseline, 3, 6, 12 & 24 months

Measured by FACT-M (Functional Assessment of Cancer Therapy - Melanoma) questionnaire - It consists of two subsections: The FACT-G subsection is a 27-item compilation of general questions divided into four primary QOL domains: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, and Functional Well-Being. It is considered appropriate for use with patients with any form of cancer. The Melanoma Surgery Subscale evaluates melanoma-specific symptoms such as surgical morbidity and side effects.

Neuropathic Pain: PainDetect questionnaireBaseline, 3, 6, 12 & 24 months

Measured by PainDetect questionnaire

Health-related Quality of Life: EQ-5D-5L questionnaireBaseline, 3, 6, 12 & 24 months

Measured by EuroQoL EQ-5D-5L questionnaire - This tool contains 5 domains including mobility, self-care, usual activities, pain/discomfort and anxiety/depression.

Health Economic EvaluationBaseline, 3, 6, 12 & 24 months

Data collected for economic analysis will be from hospital notes, MBS and PBS data (Australia) and patient reported outcome measures (including an employment questionnaire) at baseline, 3, 6, 12 and 24 months and at melanoma recurrence.

Trial Locations

Locations (189)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

🇺🇸

Orange, California, United States

Los Angeles General Medical Center

🇺🇸

Los Angeles, California, United States

USC Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Huntington Memorial Hospital

🇺🇸

Pasadena, California, United States

Stanford Cancer Center South Bay

🇺🇸

San Jose, California, United States

University of Miami Sylvester Comprehensive Cancer Center at Aventura

🇺🇸

Aventura, Florida, United States

University of Miami Sylvester Comprehensive Cancer Center at Coral Gables

🇺🇸

Coral Gables, Florida, United States

University of Miami Sylvester Cancer Center at Coral Springs

🇺🇸

Coral Springs, Florida, United States

University of Miami Sylvester Comprehensive Center at Deerfield Beach

🇺🇸

Deerfield Beach, Florida, United States

University of Miami Sylvester Comprehensive Center at Hollywood

🇺🇸

Hollywood, Florida, United States

University of Miami Miller School of Medicine-Sylvester Cancer Centre

🇺🇸

Miami, Florida, United States

University of Miami Comprehensive Cancer Center at Kendall

🇺🇸

Miami, Florida, United States

University of Miami Comprehensive Cancer Center at Plantation

🇺🇸

Plantation, Florida, United States

Advocate Illinois Masonic Medical Center

🇺🇸

Chicago, Illinois, United States

Indiana University - Melvin and Bren Simon Cancer Center

🇺🇸

Indianapolis, Indiana, United States

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

🇺🇸

Indianapolis, Indiana, United States

Franciscan Health Indianapolis

🇺🇸

Indianapolis, Indiana, United States

University of Michigan Medical Center

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan - Brighton Center for Specialty Care

🇺🇸

Brighton, Michigan, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Lovelace Medical Centre-Saint Joseph Square

🇺🇸

Albuquerque, New Mexico, United States

Lovelace Women's Hospital

🇺🇸

Albuquerque, New Mexico, United States

Northern Westchester Hospital

🇺🇸

Mount Kisco, New York, United States

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

🇺🇸

New York, New York, United States

Phelps Memorial Hospital Center

🇺🇸

Sleepy Hollow, New York, United States

University of North Carolina Hospitals - Hillsborough Campus

🇺🇸

Hillsborough, North Carolina, United States

Sanford Cancer Center Oncology Clinic

🇺🇸

Sioux Falls, South Dakota, United States

Sanford USD Medical Center - Sioux Falls

🇺🇸

Sioux Falls, South Dakota, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

University of Winsconsin Carbone Cancer Center-Eastpark medical Center

🇺🇸

Madison, Wisconsin, United States

Marshfield Medical Center- Weston

🇺🇸

Weston, Wisconsin, United States

Oak Valley Health

🇨🇦

Markham, Ontario, Canada

Centre Hospitalier de l'Universite de Montreal (CHUM)

🇨🇦

Montréal, Quebec, Canada

Cork University Hospital

🇮🇪

Cork, Ireland

Mater Misericordiae University Hospital

🇮🇪

Dublin, Ireland

St James Hospital

🇮🇪

Dublin, Ireland

Maxima Medical Centre, Eindhoven

🇳🇱

Eindhoven, Noord-Brabant, Netherlands

Diakonessenhuis

🇳🇱

Utrecht, Netherlands

Maxima Medical Center - Veldhoven

🇳🇱

Veldhoven, Netherlands

Isala Hospital

🇳🇱

Zwolle, Netherlands

Institute of Oncology Ljubljana

🇸🇮

Ljubljana, Slovenia

Lancashire Teaching Hospitals NHS Foundation Trust

🇬🇧

Preston, Lancashire, United Kingdom

University of South Alabama Mitchell Cancer Institute

🇺🇸

Mobile, Alabama, United States

Banner MD Anderson Cancer Center

🇺🇸

Gilbert, Arizona, United States

Mayo Clinic Phoenix

🇺🇸

Phoenix, Arizona, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

The Angeles (Cedars-Sinai Medical Center and its Affiliates)

🇺🇸

Los Angeles, California, United States

UC Irvine Health - Chao Family Comprehensive Cancer Center

🇺🇸

Orange, California, United States

Stanford Cancer Institute

🇺🇸

Palo Alto, California, United States

Kaiser Permanente - Vallejo Medical Center

🇺🇸

Vallejo, California, United States

Kaiser Permanente - Walnut Creek Medical Center

🇺🇸

Walnut Creek, California, United States

Smilow Hospital Care Center, Guilford

🇺🇸

Guilford, Connecticut, United States

Yale University

🇺🇸

New Haven, Connecticut, United States

MedStar Georgetown University Hospital

🇺🇸

Washington, District of Columbia, United States

MedStar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Baptist MD Anderson Cancer Center

🇺🇸

Jacksonville, Florida, United States

Mayo Clinic in Florida

🇺🇸

Jacksonville, Florida, United States

Lakeland Regional Health Hollis Cancer Center

🇺🇸

Lakeland, Florida, United States

Moffitt Cancer Center - McKinley Campus

🇺🇸

Tampa, Florida, United States

Moffitt Cancer Center, Magnolia Campus

🇺🇸

Tampa, Florida, United States

Emory University Hospital Midtown

🇺🇸

Atlanta, Georgia, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Emory Saint Joseph's Hospital

🇺🇸

Atlanta, Georgia, United States

Northside Hospital Atlanta

🇺🇸

Atlanta, Georgia, United States

Northside Hospital Cancer Institute

🇺🇸

Atlanta, Georgia, United States

Nancy N and JC Lewis Cancer & Research Pavilion St. Joseph's/Candler

🇺🇸

Savannah, Georgia, United States

Northwestern Medicine Cancer Center Kishwaukee

🇺🇸

DeKalb, Illinois, United States

Northwestern University

🇺🇸

Evanston, Illinois, United States

Northwestern Medicine Cancer Center Delnor

🇺🇸

Geneva, Illinois, United States

Northwestern Medicine Cancer Center Lake Forest Hospital

🇺🇸

Lake Forest, Illinois, United States

Advocate Lutheran General Hospital

🇺🇸

Park Ridge, Illinois, United States

Northwestern Medicine Cancer Center Warrenville

🇺🇸

Warrenville, Illinois, United States

University of Kansas Hospital - Indian Creek Campus

🇺🇸

Overland Park, Kansas, United States

University of Kansas Hospital- Westwood Cancer Center

🇺🇸

Westwood, Kansas, United States

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

MedStar Franklin Square Medical Center

🇺🇸

Baltimore, Maryland, United States

Mercy Health Saint Mary's

🇺🇸

Grand Rapids, Michigan, United States

Spectrum Health at Butterworth Campus

🇺🇸

Grand Rapids, Michigan, United States

West Michigan Cancer Centre

🇺🇸

Kalamazoo, Michigan, United States

Siteman Cancer Centre, Barnes Jewish West County

🇺🇸

Creve Coeur, Missouri, United States

University of Kansas Cancer Center

🇺🇸

Kansas City, Missouri, United States

Cox South Hospital

🇺🇸

Springfield, Missouri, United States

Nebraska Medicine - Bellevue

🇺🇸

Bellevue, Nebraska, United States

Nebraska Medicine-Village Pointe

🇺🇸

Omaha, Nebraska, United States

University of Nebraska Medicine

🇺🇸

Omaha, Nebraska, United States

Cooperman Barnabas Medical Center

🇺🇸

Livingston, New Jersey, United States

Rutgers Cancer Institute of New Jersey

🇺🇸

Piscataway, New Jersey, United States

Northwell Health Imbert Cancer Center

🇺🇸

Bay Shore, New York, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Northwell Health/Center for Advanced Medicine

🇺🇸

Lake Success, New York, United States

NYU Langone Medical Center (Winthrop Hospital)

🇺🇸

Mineola, New York, United States

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Vassar Brothers Medical Center

🇺🇸

Poughkeepsie, New York, United States

University of Rochester

🇺🇸

Rochester, New York, United States

State University of New York Upstate Medical University

🇺🇸

Syracuse, New York, United States

State University of New York Upstate Medical Center-Community Campus

🇺🇸

Syracuse, New York, United States

Wilmont Cancer Institute at Webster

🇺🇸

Webster, New York, United States

University of North Carolina at Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

East Carolina University

🇺🇸

Greenville, North Carolina, United States

Sanford Broadway Medical Centre

🇺🇸

Fargo, North Dakota, United States

Sanford Roger Maris Cancer Centre

🇺🇸

Fargo, North Dakota, United States

University Hospitals Avon Health Center

🇺🇸

Avon, Ohio, United States

Miami Valley Hospital South

🇺🇸

Centerville, Ohio, United States

University Hospitals Geauga Medical Center

🇺🇸

Chardon, Ohio, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

University Hospitals Cleveland Medical Centre

🇺🇸

Cleveland, Ohio, United States

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

University Hospitals Chagrin Highlands Medical Centre

🇺🇸

Orange Village, Ohio, United States

West Chester Hospital (OH394)

🇺🇸

West Chester, Ohio, United States

University Hospitals St. John Medical Center

🇺🇸

Westlake, Ohio, United States

OUHSC Stephenson Cancer Center

🇺🇸

Oklahoma City, Oklahoma, United States

Mercy Health Center - Oncology Hematology

🇺🇸

Oklahoma City, Oklahoma, United States

Kaiser Sunnyside Medical Center

🇺🇸

Clackamas, Oregon, United States

Kaiser Permanente Northwest - Oncology Clinic

🇺🇸

Portland, Oregon, United States

St. Luke's University Health Network - Allentown Cancer Center

🇺🇸

Allentown, Pennsylvania, United States

St Luke's University Health Network, Bethlehem Campus

🇺🇸

Bethlehem, Pennsylvania, United States

St Luke's University Health Network, Anderson Campus

🇺🇸

Easton, Pennsylvania, United States

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

St Luke's University Health Network Quakertown Campus

🇺🇸

Quakertown, Pennsylvania, United States

St. Luke's University Health Network - Upper Bucks

🇺🇸

Quakertown, Pennsylvania, United States

Guthrie Medical Group PC-Robert Packer Hospital

🇺🇸

Sayre, Pennsylvania, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

The University of Texas MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

Intermountain Medical Center

🇺🇸

Murray, Utah, United States

Huntsman Cancer Institute (The University of Utah)

🇺🇸

Salt Lake City, Utah, United States

University of Vermont Medical Center

🇺🇸

Burlington, Vermont, United States

University of Vermount and Sate Agricultural College

🇺🇸

Burlington, Vermont, United States

University of Virginia Health System

🇺🇸

Charlottesville, Virginia, United States

VCU Massey Cancer Center Peninsula Cancer Institute

🇺🇸

Newport News, Virginia, United States

VCU Massey Cancer Center

🇺🇸

Richmond, Virginia, United States

Carilion Roanoke Memorial Hospital

🇺🇸

Roanoke, Virginia, United States

VCU Massey Cancer Center Affiliate Valley Health

🇺🇸

Winchester, Virginia, United States

University of Wisconsin Carbone Cancer Center

🇺🇸

Madison, Wisconsin, United States

Marshfield Medical Center - Marshfield

🇺🇸

Marshfield, Wisconsin, United States

Aurora St Luke's Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Calvary Public Hospital Bruce

🇦🇺

Bruce, Australian Capital Territory, Australia

The Canberra Hospital

🇦🇺

Garran, Australian Capital Territory, Australia

Westmead Hospital

🇦🇺

Sydney, New South Wales, Australia

Melanoma Institute Australia

🇦🇺

Sydney, New South Wales, Australia

Royal Prince Alfred Hospital

🇦🇺

Sydney, New South Wales, Australia

Princess Alexandra Hospital

🇦🇺

Brisbane, Queensland, Australia

Robina Hospital

🇦🇺

Gold Coast, Queensland, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Peter MacCallum Cancer Centre

🇦🇺

Melbourne, Victoria, Australia

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Tom Baker Cancer Centre

🇨🇦

Calgary, Alberta, Canada

BCCA - Cancer Centre for the Southern Interior

🇨🇦

Kelowna, British Columbia, Canada

CancerCare Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

Royal Victoria Regional Health Centre

🇨🇦

Barrie, Ontario, Canada

Hamilton Health Sciences Centre

🇨🇦

Hamilton, Ontario, Canada

Ottawa Hospital Research Institute

🇨🇦

Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

UHN - Princess Margaret Cancer Centre

🇨🇦

Toronto, Ontario, Canada

Hopital Maisonneuve-Rosemont

🇨🇦

Montreal, Quebec, Canada

Hotel-Dieu de Quebec

🇨🇦

Québec City, Quebec, Canada

IOV Istituto Oncologico Veneto IRCCS-Padova

🇮🇹

Padova, Italy

Fondazione IRCCS Policlinico San Matteo

🇮🇹

Pavia, Italy

AOU Città della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

Flevo Hospital

🇳🇱

Almere, Flevoland, Netherlands

Ziekenhuis Gelderse Vallei

🇳🇱

Ede, Gelderland, Netherlands

Gelre Hospital

🇳🇱

Zutphen, Gelderland, Netherlands

University Medical Centre Groningen

🇳🇱

Groningen, Netherlands

Zuyderland Medical Center

🇳🇱

Heerlen, Netherlands

Maastricht University Medical Center

🇳🇱

Maastricht, Netherlands

North Shore Hospital

🇳🇿

Auckland, New Zealand

Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

Central Hospital Kristianstad

🇸🇪

Kristianstad, Sweden

University Hospitals Birmingham NHS Foundation Trust

🇬🇧

Edgbaston, Birmingham, United Kingdom

Royal Cornwall Hospital NHS Trust

🇬🇧

Truro, Cornwall, United Kingdom

Hull University Teaching Hospitals NHS Trust

🇬🇧

Hull, East Yorkshire, United Kingdom

MID & South Essex NHS Foundation Trust

🇬🇧

Westcliff on Sea, Essex, United Kingdom

Oxford University Hospitals NHS Foundation Trust

🇬🇧

Headington, Oxford, United Kingdom

Imperial College Healthcare NHS Trust

🇬🇧

London, The Bays, United Kingdom

Queen Victoria Hospital NHS Foundation Trust

🇬🇧

East Grinstead, West Sussex, United Kingdom

North Bristol NHS Trust

🇬🇧

Bristol, United Kingdom

Cambridge University Hospitals NHS Foundation Trust

🇬🇧

Cambridge, United Kingdom

The Leeds Teaching Hospitals NHS Trust

🇬🇧

Leeds, United Kingdom

St. Helens & Knowsley Teaching Hospitals NHS Trust

🇬🇧

Liverpool, United Kingdom

The Royal Marsden Hospital NHS Foundation Trust

🇬🇧

London,, United Kingdom

Royal Free London NHS Foundation Trust

🇬🇧

London, United Kingdom

Guy's and St Thomas's NHS Foundation Trust, of St Thomas' Hospital

🇬🇧

London, United Kingdom

St George's University Hospitals NHS Foundation Trust

🇬🇧

London, United Kingdom

The Christie NHS Foundation Trust

🇬🇧

Manchester, United Kingdom

South Tees Hospitals NHS Foundation Trust of The James Cook University Hospital

🇬🇧

Middlesbrough, United Kingdom

Norfolk and Norwich University Hospital NHS Trust

🇬🇧

Norwich, United Kingdom

Nottingham University Hospitals, NHS Trust, Trust HQ, City Hospital

🇬🇧

Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath